company background image
ASTEC logo

Astec LifeSciences NSEI:ASTEC Stock Report

Last Price

₹1.24k

Market Cap

₹24.4b

7D

-1.4%

1Y

-6.4%

Updated

25 Apr, 2024

Data

Company Financials +

Astec LifeSciences Limited

NSEI:ASTEC Stock Report

Market Cap: ₹24.4b

ASTEC Stock Overview

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India.

ASTEC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Astec LifeSciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Astec LifeSciences
Historical stock prices
Current Share Price₹1,243.75
52 Week High₹1,541.65
52 Week Low₹825.05
Beta0.34
1 Month Change12.66%
3 Month Change24.21%
1 Year Change-6.45%
3 Year Change6.71%
5 Year Change147.12%
Change since IPO1,380.65%

Recent News & Updates

Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Mar 15
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Recent updates

Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Mar 15
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

May 17
Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

Oct 14
Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Jul 27
We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

Jun 28
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Jun 03
A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

May 08
Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 06
Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 25
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

Dec 13
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Jul 21
We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

May 02
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Apr 17
The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Apr 02
Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Mar 05
Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

Feb 20
Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Feb 08
A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

Jan 28
Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Jan 17
What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 08
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Dec 28
I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Dec 18
Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Dec 07
Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

Nov 27
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares

Nov 17
Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares

Shareholder Returns

ASTECIN ChemicalsIN Market
7D-1.4%3.5%2.8%
1Y-6.4%20.4%46.6%

Return vs Industry: ASTEC underperformed the Indian Chemicals industry which returned 19.8% over the past year.

Return vs Market: ASTEC underperformed the Indian Market which returned 46.4% over the past year.

Price Volatility

Is ASTEC's price volatile compared to industry and market?
ASTEC volatility
ASTEC Average Weekly Movement6.9%
Chemicals Industry Average Movement6.5%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: ASTEC's share price has been volatile over the past 3 months.

Volatility Over Time: ASTEC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994551Anurag Roywww.astecls.com

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company’s products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols.

Astec LifeSciences Limited Fundamentals Summary

How do Astec LifeSciences's earnings and revenue compare to its market cap?
ASTEC fundamental statistics
Market cap₹24.39b
Earnings (TTM)-₹509.39m
Revenue (TTM)₹4.32b

5.6x

P/S Ratio

-47.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ASTEC income statement (TTM)
Revenue₹4.32b
Cost of Revenue₹3.06b
Gross Profit₹1.26b
Other Expenses₹1.77b
Earnings-₹509.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 02, 2024

Earnings per share (EPS)-25.98
Gross Margin29.16%
Net Profit Margin-11.80%
Debt/Equity Ratio109.2%

How did ASTEC perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

12%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.